We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Palmitic Acid Induces Posttranslational Modifications of Tau Protein in Alzheimer’s Disease–Related Epitopes and Increases Intraneuronal Tau Levels

    Metabolic diseases derived from an unhealthy lifestyle have been linked with an increased risk for develo** cognitive impairment and even...

    Valeria Melissa García-Cruz, Clorinda Arias in Molecular Neurobiology
    Article Open access 03 January 2024
  2. All-Trans Retinoic Acid-Induced Cell Surface Heat Shock Protein 90 Mediates Tau Protein Internalization and Degradation in Human Microglia

    This study investigates the role of all-trans retinoic acid (ATRA) in modulating the expression of heat shock protein 90 (Hsp90) and its influence on...

    Ngoc Lan Nguyen, Thi Xoan Hoang, Jae Young Kim in Molecular Neurobiology
    Article Open access 20 June 2024
  3. Spreading of Tau Protein Does Not Depend on Aggregation Propensity

    The stereotypical progression of Tau pathology during Alzheimer disease has been attributed to trans-neuronal spreading of misfolded Tau proteins,...

    Sara Rodrigues, Marta Anglada-Huguet, ... Eva-Maria Mandelkow in Journal of Molecular Neuroscience
    Article Open access 22 August 2023
  4. Comparison of Neuroinflammation Induced by Hyperphosphorylated Tau Protein Versus Ab42 in Alzheimer’s Disease

    Both neurofibrillary tangles and senile plaques are associated with inflammation in Alzheimer’s disease (AD). Their relative degree of induced...

    Madison Rice, Gerard J. Nuovo, ... Esmerina Tili in Molecular Neurobiology
    Article 18 December 2023
  5. Role of curcumin on beta-amyloid protein, tau protein, and biochemical and oxidative changes in streptozotocin-induced diabetic rats

    Diabetes is one of the most common endocrine metabolic diseases and is associated with the accumulation of beta-amyloid plaques in the brain. Amyloid...

    Mustafa Ermiş, Gülay Çiftci in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 26 June 2024
  6. Involvement of Fgf2-mediated tau protein phosphorylation in cognitive deficits induced by sevoflurane in aged rats

    Objective

    Anesthetics have been linked to cognitive alterations, particularly in the elderly. The current research delineates how Fibroblast Growth...

    **n **e, **aomin Zhang, ... Wei Du in Molecular Medicine
    Article Open access 16 March 2024
  7. A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization

    Background

    Soluble oligomeric forms of Tau protein have emerged as crucial players in the propagation of Tau pathology in Alzheimer’s disease (AD)....

    Nicolas De Leiris, Pascale Perret, ... Marcelle Moulin in Journal of Translational Medicine
    Article Open access 16 February 2024
  8. Toxic Tau Aggregation in AD

    Alzheimer’s disease (AD) is a neurodegenerative disorder that is caused by multiple factors, has a complicated physiopathology, and the causes of its...
    Living reference work entry 2023
  9. Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau

    Tau protein hyperphosphorylation and aggregation are key pathological events in neurodegenerative tauopathies such as Alzheimer’s disease....

    C. F. de Veij Mestdagh, M. E. Witte, ... R. E. van Kesteren in Acta Neuropathologica Communications
    Article Open access 04 June 2024
  10. Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

    Background

    Novel phosphorylated-tau (p-tau) blood biomarkers (e.g., p-tau181, p-tau217 or p-tau231), are highly specific for Alzheimer’s disease (AD),...

    Juan Lantero-Rodriguez, Gemma Salvadó, ... Oskar Hansson in Molecular Neurodegeneration
    Article Open access 17 February 2024
  11. Neuronal transcriptome, tau and synapse loss in Alzheimer’s knock-in mice require prion protein

    Background

    Progression of Alzheimer’s disease leads to synapse loss, neural network dysfunction and cognitive failure. Accumulation of protein...

    Austin Stoner, Li Fu, ... Stephen M. Strittmatter in Alzheimer's Research & Therapy
    Article Open access 15 November 2023
  12. Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases

    Background

    Autosomal dominant mutations in α-synuclein, TDP-43 and tau are thought to predispose to neurodegeneration by enhancing protein...

    Paul J. Sampognaro, Shruti Arya, ... Aimee W. Kao in Molecular Neurodegeneration
    Article Open access 02 May 2023
  13. Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice

    Tau oligomers play critical roles in tau pathology and are responsible for neuronal cell death and transmitting the disease in the brain....

    Sungsu Lim, Seulgi Shin, ... Yun Kyung Kim in Experimental & Molecular Medicine
    Article Open access 13 March 2023
  14. Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice

    Accumulation of neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau is a histopathological hallmark of Alzheimer’s disease (AD) and...

    Shuai Zhao, Ziqi Fan, ... Baorong Zhang in Neurotherapeutics
    Article Open access 23 November 2022
  15. Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau

    Mice transgenic for human mutant P301S tau are widely used as models for human tauopathies. They develop neurodegeneration and abundant filamentous...

    Manuel Schweighauser, Alexey G. Murzin, ... Michel Goedert in Acta Neuropathologica Communications
    Article Open access 05 October 2023
  16. Nuclear face of Tau: an inside player in neurodegeneration

    Tau (Tubulin associated unit) protein is a major hallmark of Alzheimer’s disease (AD) and tauopathies. Tau is predominantly an axonal protein with a...

    Neelam Younas, Tayyaba Saleem, ... Inga Zerr in Acta Neuropathologica Communications
    Article Open access 12 December 2023
  17. Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

    Tau seed amplification assays (SAAs) directly measure the seeding activity of tau and would therefore be ideal biomarkers for clinical trials...

    Bryan Frey, David Holzinger, ... Roland G. Heym in Acta Neuropathologica Communications
    Article Open access 14 November 2023
  18. Antisense oligonucleotide-based targeting of Tau-tubulin kinase 1 prevents hippocampal accumulation of phosphorylated tau in PS19 tauopathy mice

    Tau tubulin kinase-1 (TTBK1), a neuron-specific tau kinase, is highly expressed in the entorhinal cortex and hippocampal regions, where early tau...

    Kayo Yukawa, Satomi Yamamoto-Mcguire, ... Seiko Ikezu in Acta Neuropathologica Communications
    Article Open access 19 October 2023
  19. Nuclear Inhibitor of Protein Phosphatase 1 (NIPP1) Regulates CNS Tau Phosphorylation and Myelination During Development

    Nuclear inhibitor of protein phosphatase 1 (NIPP1) is a known regulator of gene expression and plays roles in many physiological or pathological...

    Cody McKee, Peter Shrager, ... Houhui **a in Molecular Neurobiology
    Article 06 October 2022
  20. The Role of Post-Translational Modifications on the Structure and Function of Tau Protein

    Involving addition of chemical groups or protein units to specific residues of the target protein, post-translational modifications (PTMs) alter the...

    Haiqiong Ye, Yue Han, ... Yongqi Huang in Journal of Molecular Neuroscience
    Article 24 March 2022
Did you find what you were looking for? Share feedback.